179 related articles for article (PubMed ID: 32205068)
1. Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.
Farukhi ZM; Demler OV; Caulfield MP; Kulkarni K; Wohlgemuth J; Cobble M; Luttmann-Gibson H; Li C; Nelson JR; Cook NR; Buring JE; Krauss RM; Manson JE; Mora S
J Clin Lipidol; 2020; 14(2):241-251. PubMed ID: 32205068
[TBL] [Abstract][Full Text] [Related]
2. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
3. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
4. Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men.
Sabaka P; Kruzliak P; Balaz D; Komornikova A; Celovska D; Cammarota G; Kusendova K; Bendzala M; Rodrigo L; Dukat A; Kwon TK; Dvorakova MC; Gaspar L
Lipids Health Dis; 2015 Nov; 14():151. PubMed ID: 26607422
[TBL] [Abstract][Full Text] [Related]
5. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
Stalenhoef AF; de Graaf J
Curr Opin Lipidol; 2008 Aug; 19(4):355-61. PubMed ID: 18607182
[TBL] [Abstract][Full Text] [Related]
6. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.
Kelley DS; Siegel D; Vemuri M; Mackey BE
Am J Clin Nutr; 2007 Aug; 86(2):324-33. PubMed ID: 17684201
[TBL] [Abstract][Full Text] [Related]
8. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
9. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
10. Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance.
Chen J; Kuang J; Tang X; Mao L; Guo X; Luo Q; Peng D; Yu B
Lipids Health Dis; 2020 Jun; 19(1):132. PubMed ID: 32522276
[TBL] [Abstract][Full Text] [Related]
11. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
[TBL] [Abstract][Full Text] [Related]
12. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
13. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
Bansal S; Buring JE; Rifai N; Mora S; Sacks FM; Ridker PM
JAMA; 2007 Jul; 298(3):309-16. PubMed ID: 17635891
[TBL] [Abstract][Full Text] [Related]
14. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
15. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
Langsted A; Nordestgaard BG
Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
[TBL] [Abstract][Full Text] [Related]
16. Echolucent, rupture-prone carotid plaques associated with elevated triglyceride-rich lipoproteins, particularly in women.
Kofoed SC; Grønholdt ML; Bismuth J; Wilhjelm JE; Sillesen H; Nordestgaard BG
J Vasc Surg; 2002 Oct; 36(4):783-92. PubMed ID: 12368740
[TBL] [Abstract][Full Text] [Related]
17. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
18. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.
Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M
Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136
[TBL] [Abstract][Full Text] [Related]
19. Changes in lipoprotein subfractions following menopause in the Longitudinal Study of Adult Health (ELSA-Brasil).
Fonseca MIH; de Almeida-Pititto B; Bensenor IM; Toth PP; Jones SR; Blaha MJ; Lotufo PA; Kulkarni KR; Ferreira SRG;
Maturitas; 2019 Dec; 130():32-37. PubMed ID: 31706433
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial.
Dutheil F; Walther G; Chapier R; Mnatzaganian G; Lesourd B; Naughton G; Verney J; Fogli A; Sapin V; Duclos M; Vinet A; Obert P; Courteix D; Lac G
Lipids Health Dis; 2014 Jul; 13():112. PubMed ID: 25015177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
